A rapid assessment of take-home naloxone provision during COVID-19 in Europe.

ABSTRACT:

Background

In March 2020, the World Health Organization declared COVID-19 a global pandemic. In the following weeks, most European countries implemented national lockdowns to mitigate viral spread. Services for people who use drugs had to quickly revise their operating procedures to rearrange service provision while adhering to lockdown requirements. Given the scarcity of literature published on overdose prevention during COVID-19 in Europe, we aimed to examine how these changes to service provision affected take-home naloxone (THN) programmes and naloxone availability across Europe.

Methods

Between November 2020 and January 2021, we conducted a rapid assessment with country experts from European countries that provide THN. We sent country experts a template to report monthl

SUBMITTER: McDonald R 

PROVIDER: S-EPMC9247228 | biostudies-literature | 2022 Sep

REPOSITORIES: biostudies-literature